|
PMID 33118022
|
FEMS Microbiol |
Millet |
2021 |
|
PMID 25428871
|
J |
Li F Receptor recognition mechanisms of |
2015 |
|
PMID 37655938
In OmniVira
|
Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats. |
Guo |
2023 |
|
PMID 30531947
|
Nat |
Cui |
2019 |
|
PMID 26855426
|
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer |
Walls AC et al |
2016 |
|
PMID 29073020
|
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion |
Walls AC et al |
2017 |
|
PMID 32155444
In OmniVira
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. |
Walls |
2020 |
|
PMID 21670291
|
Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor |
Peng G et al |
2011 |
|
PMID 33737693
|
Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2 |
Yan R et al |
2021 |
|
PMID 32142651
|
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor |
Hoffmann M et al |
2020 |
|
PMID 37879362
|
TMPRSS2 is a functional receptor for human coronavirus HKU1 |
Saunders N et al |
2023 |
|
PMID 38964328
|
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor |
McCallum M et al |
2024 |
|
PMID 36477529
In OmniVira
|
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. |
Xiong |
2022 |
|
PMID 15897467
|
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry |
Hofmann H et al |
2005 |
|
PMID 35114688
In OmniVira
|
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. |
Starr |
2022 |
|
PMID 37989312
In OmniVira
|
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus. |
Lee |
2023 |
|
PMID 36423144
|
Viruses 14, (2022) |
Lim |
2022 |
|
PMID 37421949
|
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry |
Baggen J et al |
2023 |
|
PMID 16415002
|
Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter |
Verheije MH et al |
2006 |
|
PMID 31826992
|
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry |
Wan Y et al |
2020 |
|
PMID 34579572
|
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages. MBio 12, e0198721 (2021) |
Maemura T et al |
2021 |
|
PMID 38277394
In OmniVira
|
Antibody-mediated SARS-CoV-2 entry in cultured cells. |
Kibria |
2023 |
|
PMID 35385861
|
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation |
Junqueira C et al |
2022 |
|
PMID 32907861
|
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors |
Cao L et al |
2020 |
|
PMID 37146611
|
ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines |
Hoffmann MAG et al |
2023 |
|
PMID 25517305
|
MAbs 6, 1201–1210 (2014) |
Ying |
2014 |
|
PMID 33154108
|
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 |
Xiang Y et al |
2020 |
|
PMID 32422645
|
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody |
Pinto D et al |
2020 |
|
PMID 34015271
|
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV |
Scheid JF et al. B cell genomics behind |
2021 |
|
PMID 32972994
|
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms |
Tortorici MA et al |
2020 |
|
PMID 35120603
|
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron |
Cui Z et al |
2022 |
|
PMID 33761326
|
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 |
McCallum M et al. N-terminal domain anti |
2021 |
|
PMID 35773398
|
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2 |
Sun X et al |
2022 |
|
PMID 34344823
|
Broad betacoronavirus neutralization by a stem helix-specific human antibody |
Pinto D et al |
2021 |
|
PMID 33981021
|
Structural basis for broad coronavirus neutralization |
Sauer MM et al |
2021 |
|
PMID 35857703
|
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies |
Low JS et al |
2022 |
|
PMID 32991844
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology |
Piccoli L et al |
2020 |
|
PMID 30712865
|
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion |
Walls AC et al |
2019 |
|
PMID 35017654
|
Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2 |
Zhang S et al |
2022 |
|
PMID 37507385
In OmniVira
|
Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses. |
Ou |
2023 |
|
PMID 37015915
|
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants |
Chi X et al |
2023 |
|
PMID 35714668
|
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection |
Cao Y et al |
2022 |
|
PMID 32571838
|
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 |
Chi X et al. A neutralizing human antibo |
2020 |
|
PMID 34242577
|
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies |
Li D et al |
2021 |
|
PMID 35123652
|
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection |
Beaudoin-Bussières G et al. A Fc-enhance |
2022 |
|
PMID 32645326
|
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies |
Barnes CO et al |
2020 |
|
PMID 32942285
|
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion |
Benton DJ et al |
2020 |
|
PMID 34261126
|
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape |
Starr TN et al |
2021 |
|
PMID 35412328
|
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice |
Hunt AC et al |
2022 |
|
PMID 32703906
|
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes |
Hsieh C-L et al |
2020 |
|
PMID 34751595
|
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants |
McCallum M et al |
2021 |
|
PMID 34210893
|
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern |
McCallum M et al |
2021 |
|
PMID 32150576
|
Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry |
Shang J et al |
2020 |
|
PMID 38964329
|
TMPRSS2 and glycan receptors synergistically facilitate coronavirus entry |
Wang H et al |
2024 |
|
PMID 37794193
|
Sialoglycan binding triggers spike opening in a human coronavirus |
Pronker MF et al |
2023 |
|
PMID 34098567
|
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants |
Xu J et al |
2021 |
|
PMID 32231345
|
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
Xia S et al |
2020 |
|
PMID 34326308
|
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther 6, 288 (2021) |
Xia S et al |
2021 |
|
PMID 30989115
|
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv 5, eaav4580 (2019) |
Xia S et al. A pan-coronavirus fusion in |
2019 |
|
PMID 31801868
In OmniVira
|
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection. |
Menachery |
2020 |
|
-
|
doi: 10.1101/2024.03.13.584892 |
Letko M Functional assessment of cell en |
2024 |
|
PMID 35477024
|
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry |
Qing E et al |
2022 |
|
PMID 19122397
|
J |
Takano |
2008 |
|
PMID 36757924
|
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs |
Loo L et al |
2023 |
|
PMID 19264610
|
Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus |
Schwegmann-Weßels C et al |
2009 |
|
PMID 34404805
|
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants |
Du Y et al. A broadly neutralizing human |
2021 |
|
PMID 20709108
|
J |
Whitt MA Generation of VSV pseudotypes u |
2010 |
|
PMID 32978602
|
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay |
Nie J et al |
2020 |
|
-
|
Am |
Reed LJ & Muench H A SIMPLE METHOD OF ES |
1938 |
|
PMID 34464958
|
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies |
Lempp FA et al |
2021 |
|
PMID 36356052
|
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci Immunol 7, eadf1421 (2022) |
Bowen JE et al |
2022 |
|
PMID 25504723
|
Science 346, 1377–1380 (2014) |
Russo CJ & Passmore LA Electron microsco |
2014 |
|
PMID 15890530
|
Automated molecular microscopy: the new Leginon system |
Suloway C et al |
2005 |
|
PMID 31591575
|
Nat |
Tegunov D & Cramer P Real-time cryo-elec |
2019 |
|
PMID 28165473
|
Nat |
Punjani |
2017 |
|
PMID 33257830
|
Nat |
Punjani |
2020 |
|
PMID 30713699
|
IUCrJ 6, 5–17 (2019) |
Zivanov |
2019 |
|
PMID 30412051
|
New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, (2018) |
Zivanov J et al |
2018 |
|
PMID 32148853
|
1 |
Zivanov |
2020 |
|
PMID 14568533
|
J |
Rosenthal PB & Henderson R Optimal deter |
2003 |
|
PMID 23872039
|
High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–35 (2013) |
Chen S et al |
2013 |
|
PMID 15264254
|
UCSF Chimera--a visualization system for exploratory research and analysis |
Pettersen EF et al |
2004 |
|
PMID 20383002
|
Acta Crystallogr |
Emsley |
2010 |
|
PMID 27669148
|
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. Elife 5, (2016) |
Wang RY-R et al |
2016 |
|
PMID 30344107
|
Automatically Fixing Errors in Glycoprotein Structures with Rosetta. Structure 27, 134–139.e3 (2019) |
Frenz B et al |
2019 |
|
PMID 29872003
|
Acta Crystallogr D Struct Biol 74, 519–530 (2018) |
Croll TI ISOLDE: a physically realistic |
2018 |
|
PMID 20057044
|
MolProbity: all-atom structure validation for macromolecular crystallography |
Chen VB et al |
2010 |
|
PMID 26280328
|
EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy |
Barad BA et al |
2015 |
|
PMID 26581513
|
Privateer: software for the conformational validation of carbohydrate structures |
Agirre J et al |
2015 |
|
PMID 31588918
|
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75, 861–877 (2019) |
Liebschner D et al |
2019 |
|
PMID 28710774
|
UCSF ChimeraX: Meeting modern challenges in visualization and analysis |
Goddard TD et al |
2018 |
|
PMID 16195424
|
Bats are natural reservoirs of SARS-like coronaviruses |
Li W et al |
2005 |
|
PMID 29190287
|
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus |
Hu B et al |
2017 |
|
PMID 24172901
|
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor |
Ge X-Y et al |
2013 |
|
PMID 33711082
|
A novel cell culture system modeling the SARS-CoV-2 life cycle |
Ju X et al. A novel cell culture system |
2021 |
|
PMID 36409074
|
ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells. MBio 13, e0256622 (2022) |
Guo H et al |
2022 |